Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label oral treprostinil extension study in pulmonary arterial hypertension
RBR-9q7dy5Phase 3Recruiting
- Sponsor
- Santa Casa de Porto Alegre
- Start
- Sep 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of treprostinil in pulmonary arterial hypertension (PAH), sponsored by Santa Casa de Porto Alegre. Started Sep 2013; status: recruiting.
02
Drugs
treprostinil
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on RBR-9q7dy5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-9q7dy5.